Have a feature idea you'd love to see implemented? Let us know!

NVS Novartis AG PE ratio, current and historical analysis

As of Feb 21, 2025, the Novartis AG stock's PE ratio is 18.47. This results from the current EPS of $5.92 and stock price of $109.35. The PE ratio has increased by 31% from the past four quarters average of 14.1.

NVS PE ratio history

How has NVS's PE ratio performed in the past

The PE ratio of Novartis AG has averaged 19.64 over the last ten years. The current price-to-earnings ratio of 18.47 is 6% less than the historical average. In the past ten years, NVS's PE ratio reached its highest point in the Jun 2017 quarter at 30.35, when the stock price was $83.47 and the EPS was $2.75. The lowest point was recorded in the Sep 2022 quarter, when it reached 7.77 with a price of $76.01 and an EPS of $9.78.

Today
18.47
Average
19.64
Median
18.51
Minimum
7.77
Maximum
30.35

Novartis AG PE ratio by year

Maximum annual increase: 248.1% in 2022

Maximum annual decrease: -69.29% in 2021

Year PE ratio PE change Price EPS
2024 16.44 16.43% $97.31 $5.92
2023 14.12 -50.35% $100.97 $7.15
2022 28.44 248.1% $90.72 $3.19
2021 8.17 -69.29% $87.47 $10.71
2020 26.6 43.86% $94.43 $3.55
2019 18.49 17.25% $94.69 $5.12
2018 15.77 -38.4% $85.81 $5.44
2017 25.6 -0.89% $83.96 $3.28
2016 25.83 122.1% $72.84 $2.82
2015 11.63 -47.16% $86.04 $7.4
2014 22.01 2.95% $92.66 $4.21
2013 21.38 29.34% $80.38 $3.76
2012 16.53 8.39% $63.3 $3.83
2011 15.25 10.75% $57.17 $3.75
2010 13.77 -6.39% $58.95 $4.28

Novartis AG PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 16.44 22.78% $97.31 $5.92
Sep 2024 13.39 -1.11% $115.02 $8.59
Jun 2024 13.54 3.2% $106.46 $7.86
Mar 2024 13.12 -7.08% $96.73 $7.37
Dec 2023 14.12 -48.16% $100.97 $7.15
Sep 2023 27.24 -2.3% $101.86 $3.74
Jun 2023 27.88 -0.61% $100.91 $3.62
Mar 2023 28.05 -1.37% $92 $3.28
Dec 2022 28.44 266.02% $90.72 $3.19
Sep 2022 7.77 -5.47% $76.01 $9.78
Jun 2022 8.22 1.11% $84.53 $10.28
Mar 2022 8.13 -0.49% $87.75 $10.8
Dec 2021 8.17 -56.45% $87.47 $10.71
Sep 2021 18.76 -18.15% $81.78 $4.36
Jun 2021 22.92 -5.87% $91.24 $3.98

NVS average PE ratio chart

What is the average PE ratio of NVS for the past years

The current PE ratio of NVS is above its 3-year historical average, but it is lower than the 5 and 10-year averages.

3-year avg
17.2
5-year avg
18.89
10-year avg
19.64
15-year avg
18.98

NVS PE vs peers

What is NVS's PE ratio compared to its peers

NVS's PE ratio is below its peer stocks JNJ and ABT. Novartis AG's current PE ratio of 18.47 is less than the average of its peers, which is 30.93.

Stock name PE ratio Market cap
NVS Novartis AG 18.47 $215.98B
MRK Merck & Co Inc 18.68 $226.4B
JNJ Johnson & Johnson 27.79 $390.76B
AZN Astrazeneca plc 32.7 $230.16B
PFE Pfizer Inc 34.61 $149.04B
ABT Abbott Laboratories 40.88 $234.01B
TEVA Teva Pharmaceutical Industries Ltd N/A $18.98B
BMY Bristol Myers Squibb Co N/A $113.3B

Frequently asked questions

What is Novartis AG's PE ratio?

NVS stock has a price to earnings ratio of 18.47 as of Feb 21, 2025.

What is the 3-year average PE ratio for Novartis AG (NVS)?

The 3-year average PE ratio for NVS stock is 17.2.

What is the 5-year average PE ratio for Novartis AG (NVS)?

The 5-year average PE ratio for NVS stock is 18.89.

What is the highest PE ratio for NVS?

Over the last ten years, the quarterly PE ratio reached a historic high of 30.35 in the Jun 2017 quarter.

How does the current PE ratio for NVS compare to its historical average?

NVS's price to earnings ratio is currently 6% below its 10-year historical average.

How is NVS's PE ratio calculated (Novartis AG PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Feb 21, 2025), Novartis AG's stock price is $109.35. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $5.92. Therefore, Novartis AG's price to earnings ratio for today is 18.47. PE RATIO(18.47) = STOCK PRICE($109.35) / TTM EPS($5.92)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.